PropertyValue
?:abstract
  • There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harnessing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.5334/aogh.3072
?:journal
  • Annals_of_global_health
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/c4a855ab5d7e3c69df8d391c61a8fe1c0e0946c8.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7546109.xml.json
?:pmcid
?:pmid
?:pmid
  • 33102152.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • SARS-CoV-2 Infection in Pregnant Women and Their Newborns
?:type
?:year
  • 2020-10-08

Metadata

Anon_0  
expand all